Phase II of ALS Stem Cell Trial Underway at Emory and University of Michigan

NS faculty member, Dr. Jonathan Glass, was featured in the Emory News Center and the Atlanta Business Chronicle for his research on Lou Gehrig's disease.

"We are excited to begin the next phase of this neural stem cell trial, further evaluating safety precautions, while increasing both the number of injections and cells transplanted in ALS patients," says Jonathan Glass, MD, professor of neurology, Emory School of Medicine and director of the Emory ALS Center. Glass also serves as principal investigator of the Emory clinical trial site.